The Treatment of Coronary De-novo Lesions With the Elutax Paclitaxel-eluting Balloon Alone, a Pilot Study

Inclusion Criteria: * Patient ≥ 18years old * Stable angina symptoms * Elective treatment to coronary lesion * Reference vessel diameters of ≥ 2.5mm and ≤ 4.0 mm on visual inspection Exclusion Criteria: * Left main stem lesion * Bifurcation lesions * Acute coronary syndrome (UAP, NSTEMI, STEMI) * Cardiogenic shock * Chronic total occlusion * Additional lesions requiring PCI * Platelet count ≤ 50 x 109/mm3 * Left ventricular ejection fraction ≤ 30% * Patient life expectancy less than 12 months * Known allergies to aspirin, clopidogrel, prasugrel, heparin, stainless steel, intravenous contrast (severe), or paclitaxel * Participation in another investigational drug or device study * Patient unable to give informed consent